Colin Bristow's Stock Ratings

UBS Analyst

Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 01/22/2025

Overall Average Return

-11.3%

Smart Score

Overall Average Return Percentile

18th

Number of Ratings

89

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Forecasting The Future: 23 Analyst Projections For Vertex Pharmaceuticals

Analyst Expectations For Amgen's Future

What Analysts Are Saying About Gilead Sciences Stock

Demystifying Amgen: Insights From 13 Analyst Reviews

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

Assessing Biogen: Insights From 19 Financial Analysts

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

What Analysts Are Saying About Amgen Stock

Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts

Evaluating Biogen: Insights From 17 Financial Analysts

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook